Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
Install App?
Innovations in Pharmaceutical Technology (IPT)
www.iptonline.com
This is how the Install App dialog will look like once your App goes live.
System launched at Focus on Microscopy (FOM) conference 2nd – 5th April, Porto, Portugal
3 April, 2023 -- Rome, Italy -- CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced the launch of its new spinning disk confocal microscope system, CICERO. Focusing on the essential elements of epi-fluorescence and confocal microscopy, CICERO has been developed to make high-end imaging accessible to the wider scientific community by providing a compact and cost-effective system for powerful imaging solutions.
CrestOptics’ CICERO system is an all-in-one solution for widefield and confocal imaging. Building on the recent success of the Company’s DeepSIM module as one of Microscopy Today’s ‘Top 10 Best Microscopy Innovations of 2022’, CICERO has been developed to expand the Company’s portfolio and enable accessible fluorescence imaging within one compact, budget-friendly, yet high-performing solution. The spinning disk confocal instrument can be easily integrated into existing workflows, with maximum configuration flexibility to support a seamless and user friendly transition, enabling a broad range of imaging applications across basic and applied research.
The compact system facilitates streamlined transition between widefield and confocal imaging, enabling users to simply switch between modes as their imaging requirements evolve. Widefield mode supports informative data collection from samples, such as cell monolayers and tissue sections, whereas the confocal mode allows higher-quality analysis of larger 3D structures, including organoids or whole organisms. Additionally, CICERO’s speed and light efficiency provides the capability for prolonged live imaging and the capture of fast cellular events, such as chromosome segregations and organelle trafficking.
Alessandra Scarpellini, chief commercial officer, CrestOptics, said “Studying the market, we realised that there was a need for an instrument that was equally powerful and easy to integrate into different platforms. Our team has worked hard to ensure that CICERO retains the level of technological excellence and performance that CrestOptics provides in its existing portfolio, whilst ensuring that the instrument was compact and cost-effective.”
She added: “Our systems are designed to support and advance a broad range of scientific research – in Italian, a Cicero is someone who guides individuals through journeys to see the most interesting things. True to our values, we envision our CICERO system to do just that, guide researchers’ from the start of their confocal journey and support them in more meaningful discoveries.”
CrestOptics’ CICERO system will be launched at Focus on Microscopy (FOM) 2023, 2nd- 5th April, in Porto, Portugal, including live demonstrations of the system at Booth 38/39.
About CrestOptics
CrestOptics is a leading Company in the development and manufacturing of advanced systems for fluorescence microscopy and diagnostic applications. The Company’s technology supports the research community and industrial demand with highly customised solutions thanks to a continuous improvement of its R&D and engineering strength. CrestOptics manufactures high-end microscopy instruments under its own brand and as an original equipment manufacturer (OEM). The Company’s instrumentation can be integrated with other high-end imaging systems used in life science research to enhance detection and performance of imaging. For more information, please visit https://crestoptics.com/.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/7858e175-5796-4661-97c5-764e4186ea1e.png?optimizer=image&width=360&aspect_ratio=3:4)
Avacta acquires Coris Bioconcept, gaining a broad range of marketed professional-use rapid tests
1 June 2023 -- London and Wetherby, UK -- Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to announce that it has acquired Coris Bioconcept SRL for an upfront cash consideration of £7.4m (on a debt-free/cash-free basis and subject to customary working capital adjustments), with an earnout based on future business performance, payable in cash, of up to £3m.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/b46369fa-759e-41cb-b184-d05ded988c77.png?optimizer=image&width=360&aspect_ratio=3:4)
Cellular Origins launches Constellation, a robotic platform enabling scalable therapies manufacture
31 May 2023 -- Cambridge, UK -- Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies (CGTs), has today announced the launch of Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy (ISCT) Annual Meeting 2023.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/08330a3a-870b-4752-bc12-271904e35e88.png?optimizer=image&width=360&aspect_ratio=3:4)
Qlucore presents promising results in the field of lung cancer diagnosis
30 May 2023 -- Lund, Sweden -- Qlucore can now present the first results from an EU-funded project for the improved diagnosis of lung cancer. The new classification model not only separates different subgroups of primary lung cancer but also indicates whether the tumour sample is a metastasis of breast, colorectal or kidney cell cancer. This information can have significant implications for treatment decisions in future clinical applications.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/ec4596b6-cc02-4c93-8bb1-66ceb94fbddd.png?optimizer=image&width=360&aspect_ratio=3:4)
Automata launches LINQ Cloud software to scale and manage lab automation from anywhere
24 May 2023 -- London, UK -- Automata, a leading company powering life science labs to fully automate their workflows, today launches LINQ Cloud: cutting-edge laboratory automation software. LINQ Cloud connects a lab’s physical and digital environment together, enabling life science organisations to scale while reducing the manual workload for scientists.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/18bff7dd-0e97-4096-8867-aa9304b4bbe2.png?optimizer=image&width=360&aspect_ratio=3:4)
Enhanced user experience with the latest release of Scitara’s iPaaS for science, now SOC2 certified
24 May 2023 -- Massachusetts, US -- Laboratory digital transformation pioneer, Scitara, announces new releases to its SOC 2-certified Digital Lab Exchange DLX cloud platform to improve the user experience, enhance instrument connectivity and deliver new automation to the lab.
1
Human-Centred Design: From Inception to Integration
IPT sat down with Dr Chris Vincent at PDD, to understand more about the digital innovations that are leading design and whether technologies like Extended Reality (XR) can be beneficial to the process
2
The Importance of Temperature Control in Pharmaceutical Analysis
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
3
Providing Support Throughout the Patient Journey
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
